Soligenix, Inc. SNGX 深 滬
等待開盤 10-21 09:30:00 美东时间
1.70
+0.050
+3.03%
華盛通- 最 高1.76
- 今 開1.635
- 成交量 41.30万股
- 最 低 1.635
- 昨 收 1.65
- 總市值 1676.39万
- 52周最高 6.2299
- 市盈率 靜 --
- 換手率 4.19%
- 52周最低 1.09
- 委 比 -19.24%
- 總股本 986.11万
- 歷史最高 1219.20
- 量 比 0.85
- 振 幅 7.58%
- 歷史最低 1.09
- 每 手 1
- 風險率 3.21%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Soligenix Updates U.S. Medical Advisory Board To Guide Phase 3 HyBryte Development For CTCL
Providing Strategic Medical Guidance in Advancing HyBryte™ Clinical DevelopmentPRINCETON, N.J., Oct. 14, 2025 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage
10-14 19:33
Soligenix Reports No Safety Concerns In First DMC Review Of Phase 3 HyBryte Trial For CTCL
FLASH2 Study Interim Efficacy Analysis Targeted for 1H2026Enrollment Update Remains on Track for 4Q2025PRINCETON, N.J., Oct. 7, 2025 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage
10-07 19:33
Seanergy Maritime Announces Profitable Sale of a Capesize Vessel and Expiration of Class E Warrants
Seanergy Maritime Holdings Corp. has completed the strategic sale of its Capesize vessel, M/V Geniuship, generating net cash proceeds of $12 million and an accounting profit of $2.5 million. The Class E warrants expired on August 20, 2025, with no warrants remaining outstanding. The sale aligns with the company's fleet renewal strategy, enhancing liquidity and earnings. Seanergy now has no outstanding warrants, streamlining its capital structure.
09-30 13:00
快讯 | Soligenix Inc - 于9月25日，与投资者签订证券购买协议 - SEC备案
Soligenix Inc - on Sept 25, Enters Securities Purchase Agreement With Investors...
09-30 04:26
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The company's market cap stands at $4.5 million.
09-26 20:10
Soligenix Announces Pricing of $7.5 Million Public Offering
PRINCETON, N.J., Sept. 26, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializin...
09-26 18:33
Soligenix shares are trading higher after the company appointed former White House economic adviser Tomas J. Philipson as a strategic advisor.
Soligenix shares are trading higher after the company appointed former White Ho...
09-23 19:31
'Thermostable bivalent & trivalent filovirus vaccines from insect cells: potency demonstrated after 3 months and 2 years'- Science Direct
https://www.sciencedirect.com/science/article/abs/pii/S0264410X25009818
09-04 02:14
5 Healthcare Stocks On Fire This Week
Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech & pharma.
08-21 20:24
Watching Soligenix; Zacks Small-Cap Research Gives Stock $35.00 Price Valuation
https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_08202025_SNGX_Bautz.pdf
08-20 23:00
